Natural history and profile of selective cytokines in patients of acute pancreatitis with acute kidney injury.
Acute kidney injury
Acute pancreatitis
Cytokines
Organ failure
Journal
Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
05
04
2020
revised:
12
06
2020
accepted:
13
06
2020
pubmed:
1
7
2020
medline:
6
10
2021
entrez:
29
6
2020
Statut:
ppublish
Résumé
To study the natural course of patients with acute pancreatitis (AP) with acute kidney injury (AKI) and their cytokine profile. Natural course of patients with AP and AKI was studied in 97 individuals. Levels of TNFα, IL-6, IL-10, IL-8 and IL-1β were measured at presentation and at 72 h in patients who developed AKI. Amongst the entire cohort, 16.4% patients developed AKI (persistent AKI - 11 patients, transient AKI - 5 patients). Mortality rate was 25% amongst patients with AKI. Levels of IL-6 (p = 0.035) and IL-8 (p = 0.002) were found to be significantly higher in the AKI group. On multivariate analysis, IL-8 levels at baseline were found to be an independent predictor of AKI. AKI group had significant rise of TNF-α (P < 0.001), IL-6 (P < 0.001) and IL- 1β (P < 0.001) on day 3 whereas persistent-AKI group had significant rise of TNF-α (p = 0.031), IL-6 (p = 0.001) and IL-1β on day 3 and significant decline of IL-10 (p = 0.015). Using a cut-off of 105 pg/ml, IL-8 levels at baseline could predict AKI with a sensitivity of 87.5% and specificity of 59.2%, with area under the curve being 0.744 (p = 0.002). AP patients developing AKI have poor prognosis. IL-8 levels can predict AKI in patients with AP.
Identifiants
pubmed: 32593952
pii: S1043-4666(20)30193-9
doi: 10.1016/j.cyto.2020.155177
pii:
doi:
Substances chimiques
Cytokines
0
Interleukin-1beta
0
Interleukin-6
0
Interleukin-8
0
Tumor Necrosis Factor-alpha
0
Interleukin-10
130068-27-8
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
155177Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.